We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
MarineMax
HZO
$1.16B
| $2.28M | 0.01% |
63,089
+18,223
| +41% | +$732K |
|
1052
Northwest Natural Holdings
NWN
$2.12B
| $2.27M | 0.01% |
42,695
+286
| +0.7% | +$14.8K |
|
|
GTY
1053
Getty Realty Corp
GTY
$2B
| $2.25M | 0.01% |
84,824
-447
| -0.5% | -$12.2K |
|
|
AGEN
1054
Agenus
AGEN
$307M
| $2.24M | 0.01% |
58,940
+32,394
| +122% | +$1.18M |
|
1055
Lamb Weston
LW
$7.23B
| $2.24M | 0.01% |
31,517
-37,452
| -54% | -$2.47M |
|
1056
Autoliv
ALV
$8.96B
| $2.24M | 0.01% |
31,869
+28,936
| +987% | +$2.16M |
|
1057
Innoviva
INVA
$1.5B
| $2.23M | 0.01% |
151,429
+20,359
| +16% | +$333K |
|
1058
Horizon Bancorp
HBNC
$1.05B
| $2.23M | 0.01% |
127,705
+31,376
| +33% | +$558K |
|
1059
Safety Insurance
SAFT
$1.52B
| $2.22M | 0.01% |
22,891
-1,224
| -5% | -$110K |
|
1060
Nutanix
NTNX
$17.4B
| $2.22M | 0.01% |
156,509
-212,087
| -58% | -$4.42M |
|
1061
O-I Glass
OI
$1.1B
| $2.21M | 0.01% |
158,399
+11,139
| +8% | +$160K |
|
|
EVRI
1062
DELISTED
Everi Holdings
EVRI
| $2.18M | ﹤0.01% |
133,913
+49,821
| +59% | +$877K |
|
1063
Fabrinet
FN
$18.8B
| $2.18M | ﹤0.01% |
26,885
+2,360
| +10% | +$212K |
|
|
WW
1064
DELISTED
WW International
WW
| $2.18M | ﹤0.01% |
344,359
+140,742
| +69% | +$1.18M |
|
|
EMKR
1065
DELISTED
Emcore Corp
EMKR
| $2.17M | ﹤0.01% |
70,667
+20,158
| +40% | +$679K |
|
1066
Corcept Therapeutics
CORT
$12.1B
| $2.17M | ﹤0.01% |
91,172
+7,788
| +9% | +$170K |
|
1067
StoneX
SNEX
$7.96B
| $2.16M | ﹤0.01% |
140,201
-11,218
| -7% | -$162K |
|
1068
Magnolia Oil & Gas
MGY
$6.16B
| $2.15M | ﹤0.01% |
102,308
+12,415
| +14% | +$310K |
|
1069
MillerKnoll
MLKN
$1.62B
| $2.15M | ﹤0.01% |
82,544
+66,948
| +429% | +$2.03M |
|
1070
California Water Service
CWT
$3.09B
| $2.14M | ﹤0.01% |
38,599
-10,013
| -21% | -$539K |
|
1071
Fulgent Genetics
FLGT
$523M
| $2.14M | ﹤0.01% |
39,207
+4,824
| +14% | +$265K |
|
1072
HUB Group
HUBG
$2.32B
| $2.14M | ﹤0.01% |
60,280
-19,864
| -25% | -$696K |
|
1073
Signet Jewelers
SIG
$3.68B
| $2.14M | ﹤0.01% |
39,968
-6,046
| -13% | -$394K |
|
|
HTB
1074
HomeTrust Bancshares
HTB
$830M
| $2.12M | ﹤0.01% |
84,816
+11,886
| +16% | +$322K |
|
1075
Ventas
VTR
$44.6B
| $2.12M | ﹤0.01% |
41,372
-79,595
| -66% | -$4.46M |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.